Vinorelbine/epirubicin vs AC in operable breast cancer

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1515, 2005-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epirubicin + vinorelbine vs FEC100 for node-positive breast cancer

By  

Inpharma, Vol. 1, Iss. 1596, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Neoadjuvant Dose-Dense Gemcitabine plus Docetaxel and Vinorelbine plus Epirubicin for Operable Breast Cancer: Improved Prognosis in Triple-Negative Tumors

By Medioni Jacques   Huchon Cyrille   >  

Drugs in R&D, Vol. 11, Iss. 2, 2011-06 ,pp. : 147-157

Adis International

Access to resources Recommend Favorite

Epirubicin plus vinorelbine useful in advanced breast cancer

By  

Inpharma, Vol. 1, Iss. 1453, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

The combination of cisplatin, epirubicin and vinorelbine effectively treats advanced breast cancer

By  

Inpharma, Vol. 1, Iss. 1428, 2004-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Liposomal doxorubicin vs epirubicin in breast cancer

By  

Inpharma, Vol. 1, Iss. 1462, 2004-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite